Rajni Kumari

I am a Postdoctoral Fellow under the supervision of Dr. Ulrich Steidl at Albert Einstein College of Medicine, NY and currently studying the role of H2.0 homeobox-like protein, called Hlx in short, in the development and maintenance of acute myeloid leukemia (AML). Hlx is overexpressed in 80% of AML patients at transcript level. However, we lack the understanding of this protein’s function at molecular level.